Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation

Journal of Immunology

Volumn 168, Issue 6, 2002, Pages 2904-2913

  Bacci, Angela ^a   Montagnoli, Claudia ^a   Perruccio, Katia ^a   Bozza, Silvia ^a   Gaziano, Roberta ^a   Pitzurra, Lucia ^a   Velardi, Andrea ^a   D'Ostiani, Cristiana Fe' ^a   Cutler, Jim E ^a   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS VACCINE; FUNGAL RNA; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CANDIDA ALBICANS; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FUNGUS HYPHAE; GENETIC TRANSFECTION; IMMUNITY; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; TH1 CELL;

EID: 0037087437     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.6.2904     Document Type: Article

References (62)

1. Invasive Candida infections: Evolution of a fungal pathogen
2. The role of cell-mediated immunity in candidiasis
3. A Th1-Th2-like switch in candidiasis: New perspectives for therapy
4. Immunity to Candida albicans: Th1, Th2 and beyond
5. Biological role of helper T-cell subsets in candidiasis
6. Cell wall and secreted proteins of Candida albicans: Identification, function, and expression
7. Candida albicans hyphal formation and virlence: Is there a clearly defined role?
8. Nonfilamentous C. albicans mutants are avirulent
9. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1
10. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans: Implications for initiation of T helper cell immunity in vitro and in vivo
11. Dendritic cells and the control of immunity
12. Human dendritic cells phagocytose and process Borrelia burgdorferi
13. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex-vivo with nonviable Chlamydiae
14. Dendritic cells efficiently induce protective antiviral immunity
15. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
16. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice
17. Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus
18. Antigen- presenting cells: Experimental and clinical studies of dendritic cells
19. Clinical application of dendritic cell vaccines
20. Active immunization of humans with dendritic cells
21. Dendritic cells resurrect antigens from dead cells
22. Dendritic cells pulsed with RNA are potent antigen presenting cells in vitro and in vivo
23. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUCI RNA
24. RNA transfected dendritic cells as cancer vaccines
25. Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists
26. Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins
27. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice
28. + stem cells: A new option for leukemia patients without an HLA matched donor
29. A simple and inexpensive method for RNA extraction from yeasts
30. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colonystimulating factor
31. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes
32. Cationic lipids direct a viral glycoprotein into the class 1 major histocompatibility complex antigen-presentation pathway
33. Antibody response that protects against disseminated candidiasis
34. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies
35. + subset expression in murine candidiasis: Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance
36. Early T cell unresponsiveness in mice with candidiasis and reversal by IL-2: Effect on T helper cell development
37. Species and genotypic diversities and similarities of pathogenic yeasts colonizing women
38. Candida albicans mannan extractprotein conjugates induce a protective immune response against experimental candidiasis
39. Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo
40. Antigen-specific inhibition of effector function in humans after injection of immature dendritic cells
41. Distribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration
42. T cell activity after dendritic cell vaccination is dependent on both the type of antigen the mode of delivery
43. Dendritic cells injected via different routes induce immunity in cancer patients
44. Dendritic cells: On the move from bench to bedside
45. +) cell population in the reconstitution phase after human bone marrow transplantation
46. Analysis of T cell repopulation after allogeneic marrow transplantation: Significant differences between recipients of T cell depleted and unmanipulated grafts
47. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusion on T-cell repertoire
48. Dendritic cells in transplantation: Friend or foe?
49. The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation
50. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice
51. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells
52. Differentiation of T regulatory cells by immature dendritic cells
53. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo
54. + suppressor T cells
55. Fully competent dendritic cells as inducers of T cell anergy in autoimmunity
56. Interleukin-4 and -10 exacerbate candidiasis in mice
57. + T helper type 1 cell responses to Candida albicans
58. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity
59. + T cells in vitro
60. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells
61. Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells